Metastatic follicular carcinoma associated with hyperthyroidism

Area of Science:

• Endocrinology
• Oncology
• Genetics

Background:

• Follicular thyroid carcinoma can present with metastatic disease and endocrine dysfunction.
• Hyperthyroidism in the context of thyroid cancer requires careful investigation of underlying mechanisms.

Observation:

• A 68-year-old male with metastatic follicular thyroid carcinoma exhibited T3 hyperthyroidism and intense radioactive iodine (I-131) uptake in the thyroid and bone metastases.
• Hyperthyroidism persisted post-thyroidectomy and was only transiently managed by I-131 therapy.
• Molecular analyses ruled out common mutations in the thyrotropin receptor and Gs alpha subunit, and thyroid-stimulating receptor antibodies were unlikely causes.

Findings:

• Comparative genomic hybridization revealed multiple chromosomal imbalances in the tumor.
• I-131 treatment provided only a 9-month euthyroid state, with no impact on tumor progression.
• The precise etiology of the persistent hyperthyroidism remained undetermined, with type 2 deiodinase overexpression being unlikely due to genetic findings.

Implications:

• This case highlights the complexity of managing hyperthyroidism associated with metastatic follicular thyroid carcinoma.
• Further research is needed to elucidate the mechanisms driving hormone production in such rare thyroid cancer presentations.
• Understanding the genetic underpinnings of thyroid cancer-associated hyperthyroidism is crucial for developing effective therapeutic strategies.